Entac -Noninvasive Devices for Predictive and Diagnostic Medicine
Developing noninvasive devices for precision medicine based on novel, patented platform technology.
Postoperative ileus (POI) is acute paralysis of the GI tract that develops 2-6 days after surgery causing nausea and vomiting, abdominal pain and distention. It occurs in many types of surgery, with highest incidence in gastrointestinal surgery where over 2 million patients are at risk annually in the US alone. The inability to predict which patients will develop POI leads to increased postoperative complications, longer length of stay, and high readmission rates.
PrevisEA is a small, self-contained, noninvasive device attached to the patient’s abdomen after surgery. Using proprietary algorithms to detect a highly specific, clinically proven biomarker that is highly correlated with the development of POI. PrevisEA, used in the hours following surgery, is highly accurate in predicting future development of POI. Personalizing postoperative care based upon accurate prediction of POI can:
- Dramatically reduce readmissions due to POI developing at home
- Avoid exacerbation of POI by early feeding
- Reduce postoperative complications
- Reduce length of stay
- Save millions of dollars in total treatment costs and maximize reimbursement
The inability to predict which patients will develop POI leads to failures in optimization of postoperative care.
- Can my patient be re-fed without concern for POI developing 2-6 days from now?
- When can I discharge my patient without concern of him/her developing POI at home?
Surgeons have never been able to answer these questions, until now…